▶주메뉴 바로가기

▶본문 바로가기

The Korea Herald
검색폼

THE INVESTOR
April 20, 2024

Stocks & Bonds

[STOCK WATCH] Ilyang Pharmaceutical falls 1.97%

  • PUBLISHED :July 18, 2017 - 14:57
  • UPDATED :July 18, 2017 - 14:57
  • 폰트작게
  • 폰트크게
  • facebook
  • sms
  • print
[THE INVESTOR] As of July 18 02:10 P.M., Ilyang Pharmaceutical declined 1.97%, compared with yesterday, to 37,300 won(US$33.20). It had declined 12.03% through the past month. Standard deviation, the volatility index for stock price, was 1.6% on the same period of time over one month.

Compared with its close competitors within the same industry, KOSPI, since the monthly volatility of Ilyang Pharmaceutical was at a low level, the earnings rate over one month was also relatively lower than that of its peer group. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was -7.5%. 

The return-on-risk is below the industrial mean, 4.2, and thus it is hard to say that the industrial comparison performance was positive.

By HeRo (hero@heraldcorp.com)
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.

EDITOR'S PICKS